Knowing the Python packaging ecosystem, uv could very well be replaced by something else. It feels different this time, but we won't know for a while yet.
1. By way of self-inflicted damage
Funding the research privately increases costs to end user as private ensurer is directly accruing more cost. Research stopping increases costs to end user as new/novel cures/treatments aren't found.
Cost for consumer goes up because of lost opportunity cost of 1) learning to diagnose earlier 2) finding new or cheaper cures/treatments.
You can make the argument 'But other countries will pick up the slack!' - but that doesn't necessarily help either, why would they give us the results of their research cheaper? US already jacked up pricing via an executive order on drug pricing just this year to knock that.
Publicly funded medical research is an absolute positive for the US general public health and wallets. We're all losing here on both ends of the spectrum ($$ and actual general public health).
What really turned me into a touch-typist was all the arguing I did over dial-up internet the next summer.
Let's see: we have Claude Code vs. Claude the API vs. Claude the website, and they're totally different from each other? One is command line, one integrates into your IDE (which IDE?) and one is just browser based, I guess. Then you have the different pricing plans, Free, Pro, and Max? But then there's also Claude Team and Claude Enterprise? These are monthly plans that only work with Claude the Website, but Claude Code is per-request? Or is it Claude API that's per-request? I have no idea. Then you have the models: Claude Opus and Claude Sonnet, with various version numbers for each?? Then there's Cline and Cursor and GOOD GRIEF! I just want to putz around with something in VSCode for a few hours!